SAT-383 Rapid analysis of HBV-specific T cell secretomes reveals distinct antiviral immune profiles among chronic HBV patients
Nina Le Bert(Duke-NUS Medical School), Patrick Kennedy(Queen Mary University of London), Rajneesh Kumar(Singapore General Hospital), Smrithi Hariharaputran, Antonio Bertoletti(Duke-NUS Medical School), Wan Cheng Chow, Lung‐Yi Mak(Queen Mary Hospital), Anthony T. Tan(Duke-NUS Medical School), Upkar S. Gill(Queen Mary University of London), Shou Kit Hang, Yifei Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Lei Yu(University of Science and Technology of China), Apostolos Koffas, Qi Chen(BGI Group (China)), Tizong Miao(Queen Mary University of London)
Cited by 0
Related Papers
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
|Journal of Hepatology|2020|525
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡
|Journal of Hepatology|2019|364
A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors
|JCI Insight|2017|239